TSEE - ETF AI Analysis
Top Page
T. Rowe Price Small Cap ETF (TSEE)
Rating:60Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several of the largest positions, especially in health care and related names, have shown strong gains so far this year, helping support the ETF’s overall results.
Broad Sector Diversification
The fund spreads its assets across many different sectors, which can help reduce the impact if any single industry runs into trouble.
Focused Small-Cap Exposure
By concentrating on smaller companies, the ETF offers investors targeted exposure to a part of the market that can provide higher growth potential over time.
Negative Factors
High U.S. Concentration
Most of the portfolio is invested in U.S. stocks, which limits the diversification benefits from other regions and ties performance closely to the U.S. economy.
Elevated Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns are used to cover fees instead of going to investors.
Mixed Performance Among Top Holdings
While several leading positions have performed well, at least one notable holding has been weak this year, which can drag on the fund’s overall performance.
TSEE vs. SPDR S&P 500 ETF (SPY)
AUM10.43M
RegionNorth America
Expense Ratio0.59%
BetaN/A
IssuerT. Rowe Price
Inception DateSep 17, 2026
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,070
30 Day Avg. Volume1,932
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
33.29Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering221
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TSEE Summary
The T. Rowe Price Small Cap ETF (TSEE) is an actively managed fund that focuses on smaller U.S. companies, rather than tracking a set index. It spreads investments across many industries, including health care, financials, and industrials, with top holdings like Dyne Therapeutics and Grocery Outlet. Someone might invest in TSEE to seek long-term growth and diversify beyond large, well-known stocks by adding smaller, up-and-coming businesses. However, because it invests in small companies, the share price can be more volatile and may rise and fall more sharply than the overall market.
How much will it cost me?This ETF has an expense ratio of 0.59%, which means you’ll pay about $5.90 per year for every $1,000 you invest. That’s higher than the average index ETF because this fund is actively managed, where professional managers research and select small-cap stocks rather than simply tracking a benchmark.
What would affect this ETF?This ETF could benefit if the U.S. economy stays healthy, small-cap companies regain investor interest, and sectors like health care, financials, and industrials see steady growth or supportive regulations that help smaller businesses expand. On the other hand, rising interest rates, an economic slowdown in the U.S., or setbacks in health care and energy companies could hurt many of its holdings and make the fund more volatile than large-cap-focused investments.
TSEE Top 10 Holdings
This small-cap ETF leans heavily into U.S. health care innovators, with names like Repligen, Kymera Therapeutics, Immunome, and BrightSpring Health Services doing much of the heavy lifting as their shares have been rising or showing strong momentum despite shaky profitability. Dyne Therapeutics, on the other hand, has been lagging and acts as a bit of a speed bump in the portfolio’s biotech lane. Outside of health care, steadier contributors like TMX Group and InterDigital help balance the ride, but the story here is clearly high-octane, research-driven small-cap growth in the U.S.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Liberty Media Corp. Series C Liberty Live | 2.04% | $200.52K | $8.90B | 5.97% | ― | |
| Dyne Therapeutics | 1.77% | $173.88K | $3.01B | 28.88% | 43 Neutral | |
| InterDigital | 1.57% | $154.37K | $8.41B | -6.41% | 76 Outperform | |
| TMX Group | 1.54% | $151.99K | $10.11B | -2.71% | 70 Outperform | |
| Repligen | 1.53% | $150.40K | $10.85B | 31.84% | 68 Neutral | |
| Immunome | 1.27% | $125.15K | $2.44B | 89.68% | 63 Neutral | |
| BrightSpring Health Services, Inc. | 1.27% | $125.14K | $11.23B | 97.39% | 67 Neutral | |
| Kymera Therapeutics | 1.25% | $123.11K | $9.30B | 104.52% | 56 Neutral | |
| OR Royalties | 1.24% | $121.68K | $6.39B | -14.56% | 70 Outperform | |
| Grocery Outlet Holding | 1.23% | $121.25K | $1.11B | -30.56% | 52 Neutral |
TSEE Technical Analysis
Neutral
―
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TSEE, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of ―, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSEE.
TSEE Peer Comparison
Comparison Results
Performance Comparison
TSEE
T. Rowe Price Small Cap ETF
24.88
-0.24
-0.96%
AIMS
Acuitas Small Cap Active ETF
―
―
―
RUSC
US Small Cap Equity Active ETF
―
―
―
SYZ
Lazard US Systematic Small Cap Equity ETF
―
―
―
ESSC
Eventide Small Cap ETF
―
―
―
FTKI
First Trust Small Cap BuyWrite Income ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents